Approvals/CIMA-AEMPS/BORTEZOMIB WAVERLEY 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG

Approved

STANDARD

BORTEZOMIB WAVERLEY 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG

Waverley Pharma Europe Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 9b6948cbe9357001
Drug Cima Aemps Name: BORTEZOMIB WAVERLEY 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG
Register Number: 85002
Holder Company Name: Waverley Pharma Europe Limited
Marketing Company Name: Viso Farmaceutica S.L.U.
Authorization Date: 2020-06-25
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE
Dose: 3,5 mg
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Waverley Pharma Europe Limited

BORTEZOMIB

3,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 25, 2020

Approval ID

9b6948cbe9357001

Type

Standard